Dengue vaccine immunity study for all ages
Part of Infections clinical trials.
This study looks at how the dengue vaccine works in people with and without past exposure to dengue or similar viruses like yellow fever or Zika. Volunteers receiving the dengue vaccine will give blood samples to help researchers understand the immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 4 years or older.
- You are planning to get the dengue vaccine at the study clinic.
- You may or may not have had a past dengue, Zika, yellow fever, or other related virus infection or vaccine.
- You are willing to provide blood samples before and after vaccination.
- You or your parent/guardian can sign a consent form.
- No other requirements—this study is open to many people.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new dengue vaccine in adults aged 40 to 79 to see if it can protect them from dengue fever. If you are generally healthy and willing to follow the study schedule, you may be able to join.
This study tests a dengue vaccine (TDV) in adults aged 45 to 79. It aims to see if the vaccine is safe and effective, even for people with common health conditions like diabetes or high blood pressure.
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
This study tests a controlled dengue infection in people who already have immunity to some types of dengue. It aims to understand how the immune system responds and to help develop better vaccines. You may qualify if you are a healthy adult aged 18-40 and have evidence of prior dengue exposure to certain virus types.
This study tests if a two-dose dengue vaccine works better than the standard single dose for children and teens who have never had dengue. It also checks if the vaccine works the same when made at a different factory.
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
Hear when a new Dengue Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.